Omeros (OMER) Times Interest Earned (2010 - 2026)
Omeros' (OMER) quarterly Times Interest Earned came in at -$2.96 in Q1 2026, up 69.11% year-on-year from -$1.75 in Q1 2025, and up 11.31% quarter-over-quarter from -$3.33 in Q4 2025.
Omeros (OMER) Times Interest Earned (2010 - 2026) Analysis & Trends
Omeros has disclosed Times Interest Earned across 17 years of filings, most recently posting -$2.96 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$2.96, up 69.11% year-over-year; the trailing twelve-month figure through Mar 2026 was -$82.22 (down 914.54% YoY), and the FY2025 annual result was $127.91, up 138.31% from the prior year.
- Times Interest Earned came in at -$2.96 for Q1 2026 at Omeros, up from -$3.33 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $1.98 in Q3 2025 to a low of -$2156.9 in Q2 2025.
- The 5-year median for Times Interest Earned is -$6.08 (2023), against an average of -$132.51.
- Peak annual rise in Times Interest Earned reached 122.62% in 2025, while the deepest fall reached 33498.97% in 2025.
- Omeros' Times Interest Earned stood at -$5.08 in 2022, then slipped by 10.85% to -$5.63 in 2023, then plunged by 86.48% to -$10.5 in 2024, then jumped by 68.26% to -$3.33 in 2025, then rose by 11.31% to -$2.96 in 2026.
- The last three Times Interest Earned figures came in at -$2.96 (Q1 2026), -$3.33 (Q4 2025), and $1.98 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | -2.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.96 |
| Dec 31, 2025 | -3.33 |
| Sep 30, 2025 | 1.98 |
| Jun 30, 2025 | -2,156.93 |
| Mar 31, 2025 | -9.57 |
| Dec 31, 2024 | -10.50 |
| Sep 30, 2024 | -8.74 |
| Jun 30, 2024 | -6.42 |
| Mar 31, 2024 | -4.74 |
| Dec 31, 2023 | -5.63 |
| Sep 30, 2023 | -6.08 |
| Jun 30, 2023 | -5.16 |
| Mar 31, 2023 | -4.50 |
| Dec 31, 2022 | -5.08 |
| Sep 30, 2022 | -10.29 |
| Jun 30, 2022 | -7.60 |
| Mar 31, 2022 | -7.09 |
| Dec 31, 2021 | -8.66 |
| Sep 30, 2021 | -8.11 |
| Jun 30, 2021 | -9.29 |